Industry Research Reports and Market Analysis at MindBranch.com

Medicated Skincare Products - US

Published By: Mintel International Group Ltd.
May 2009
R560-3902
Online Download   $3,995.00
Hard Copy Mail Delivery   $3,995.00 (Subject to Shipping Charges)
Global Site License   $6,000.00
Description

With consumers looking for any way possible to save money, there is a prime opportunity for manufacturers within the medicated skincare category to lure consumers in with products that promise the same benefits as doctors’ services, but at a much lower cost. This has already taken place to a certain extent, with wart removal preparations that freeze off warts, something that was once solely the purview of doctors. And consumers no longer have to run to the doctor to get a prescription for Zovirax to take care of their cold sores.

However, suppliers can further emphasize their similarity to what a doctor would do. Polysporin, for example, could note that the use of Polysporin right away on a cut could prevent that cut from getting infected and requiring a trip to the physician. Similarly, anti-itch formulations could point out that severe itching can lead to cuts and subsequent infections, all of which could be initially alleviated with the use of anti-itch medicines.
Table of Contents
SCOPE AND THEMES
What you need to know
Definition
Data sources
Sales data
Consumer survey data
Abbreviations and terms
Abbreviations
Terms
EXECUTIVE SUMMARY
A slow-growth industry
Paradoxically, a poor economy may be driving growth
Sales of first aid treatments still corner the market, though lip balm/cold sore medications show
strongest growth
Retail channel preferences
Facial skincare consumers
Athlete’s foot and antibiotic ointments
MARKET SIZE AND FORECAST
Key points
Consumers looking for DIY remedies
Figure 1: U.S. FDMx sales of medicated skincare, at current prices, 2003-13
Figure 2: U.S. FDMx sales of medicated skincare, at inflation-adjusted prices, 2003-13
Walmart sales
COMPETITIVE CONTEXT
Doctor visits when necessary
Drop in consumer confidence drives the “do nothing scenario” and private label sales
SEGMENT PERFORMANCE
Key points
Economy clearly having an impact
Figure 3: U.S. FDMx sales of medicated skincare, segmented by type, 2006 and 2008
SEGMENT PERFORMANCE—FIRST AID
Key points
More consumers taking care of smaller problems at home
Figure 4: U.S. FDMx sales of first aid, at current prices, 2003-13
SEGMENT PERFORMANCE—LIP BALM/COLD SORE MEDICATIONS
Key points
Consumers willing to self-medicate
Figure 5: U.S. FDMx sales of lip balm/cold sore medication, at current prices, 2003-13
SEGMENT PERFORMANCE—ACNE TREATMENTS
Key point
Acne treatments continue to have their audience
Figure 6: U.S. FDMx sales of acne treatments, at current prices, 2003-13
SEGMENT PERFORMANCE—FOOT CARE/ATHLETE’S FOOT TREATMENTS
Key points
Growth of foot care products stagnating
Figure 7: U.S. FDMx sales of foot care products, at current prices, 2003-13
SEGMENT PERFORMANCE—ANTI-ITCH TREATMENTS
Key points
A lack of innovation has not hurt sales
Figure 8: U.S. FDMx sales of anti-itch treatments, at current prices, 2003-13
SEGMENT PERFORMANCE—WART REMOVERS
Key point
Little growth seen in wart removal market
Figure 9: U.S. FDMx sales of wart removers, at current prices, 2003-13
SEGMENT PERFORMANCE—LICE TREATMENT
Key points
The stigma of lice
Figure 10: U.S. FDMx sales of lice treatments, at current prices, 2003-13
MARKET DRIVERS
Number of teens declining
Figure 11: Teen population, by age, 2008
Rise in incidence of diabetes drives need for foot care
High rate of obesity contributes to demand for foot care products
Total population drives the market; but aging Baby Boomers presents opportunities
Figure 12: Population by age, 2004-14
LEADING COMPANIES
Key points
Johnson & Johnson has its footprint visible with regard to many segments
Figure 13: FDMx sales of medicated skincare, by leading manufacturers, 2006 and 2008
BRAND SHARE—FIRST AID TREATMENT
Key points
Slight gains by some brands, but private label dominates
Figure 14: FDMx brand sales of first aid treatment in the U.S., 2006 and 2008
BRAND SHARE—LIP BALM/COLD SORE TREATMENT
Key points
Burt’s Bees holding its own despite controversy
Figure 15: FDMx brand sales of lip balm/cold sore treatment in the U.S., 2006 and 2008
BRAND SHARE—ACNE TREATMENT
Key points
Old favorites lose ground
Private label rises as economy sinks
Figure 16: FDMx brand sales of acne treatments in the U.S., 2006 and 2008
BRAND SHARE—ATHLETE’S FOOT TREATMENT
Key points
With private label readily available, brand sales decline
Figure 17: FDMx brand sales of athlete’s foot treatment in the U.S., 2006 and 2008
BRAND SHARE—ANTI-ITCH TREATMENT
Key points
Consumers reach for the familiar, but also try to cut costs
Figure 18: FDMx brand sales of anti-itch treatment in the U.S., 2006 and 2008
BRAND SHARE—WART REMOVAL TREATMENT
Key points
A stagnant market for wart removal
Figure 19: FDMx brand sales of wart removal treatment in the U.S., 2006 and 2008
BRAND SHARE—LICE TREATMENT
Key points
A category no one wants to talk about
Figure 20: FDMx brand sales of lice treatment in the U.S., 2006 and 2008
BRAND QUALITIES
ChapStick
Clearasil
BENGAY
Dr. Scholl’s
Burt’s Bees
INNOVATION AND INNOVATORS
3M Nexcare Microvex
Johnson & Johnson
SkiniD
Kiss My Face
Neutrogena Dermatologics
RETAIL CHANNELS
Key point
FDMx sales
Figure 21: U.S. sales of medicated skincare, by retail channel, 2006 and 2008
RETAIL CHANNELS—DRUG STORES
Key point
Drug stores remain in the lead in medicated skincare
Figure 22: U.S. sales of medicated skincare at drug stores, 2003-08
RETAIL CHANNELS—MASS MERCHANDISERS AND FOOD STORES
Key point
Food stores and mass merchandisers try to compete
Figure 23: U.S. sales of medicated skincare at food stores, 2003-08
ADVERTISING AND PROMOTION
Figure 24: Television Ad for Activ On, 2008
Figure 25: Television ad for Clearasil Pimple Blocker Pen, 2008
Figure 26: Television ad for Compound W, 2008
Figure 27: Television ad for Gold Bond, 2008
Figure 28: Television ad for Orajel Overnight, 2008
Figure 29: Television ad for Polysporin Complete, 2008
MEDICATED SKINCARE USAGE
Usage of medicated skincare products
Figure 30: Medicated skincare products used, by gender, July 2007-September 2008
Figure 31: Medicated skincare products used, by age, July 2007-September 2008
Usage of different types of products
Figure 32: Form of medicated skincare products used, by gender, July 2007-September 2008
Figure 33: Form of products used, by age, July 2007-September 2008
PRODUCT ATTRIBUTES & BRANDS
Product attributes
Figure 34: Attributes found in medicated skincare products typically used, by gender, July 2007-September
2008
Figure 35: Attributes found in skincare products typically used, by age, July 2007-September 2008
Brands used
Figure 36: Brand of facial cleansing or medicated product used, by gender, July 2007-September 2008
Figure 37: Brand of facial cleansing or medicated product used, by age, July 2007-September 2008
REMEDY FORMATS AND CONDITION INCIDENCE
Usage of first aid/antibiotic remedies
Figure 38: First aid used, by gender, July 2007-September 2008
Figure 39: First aid used, by age, July 2007-September 2008
Usage of different types of products
Figure 40: Types of first aid products used, by gender, July 2007-September 2008
Figure 41: Types of first aid products used, by age, July 2007-September 2008
Brand of first aid product used
Figure 42: Brand of first aid product used, by gender, July 2007-September 2008
ASSORTED AILMENTS/SKINCARE ISSUES AND TREATMENT
Prevalence of skincare issues
Figure 43: Prevalence of skincare issues, by gender, July 2007-September 2008
Figure 44: Prevalence of skincare issues, by age, July 2007-September 2008
Treating athlete’s foot—prescription vs. non-prescription products
Figure 45: Usage of prescription products, by gender, July 2007-September 2008
Figure 46: Usage of prescription products, by age, July 2007-September 2008
Treating eczema/psoriasis—prescription vs. non-prescription products
Figure 47: Usage of prescription products, by gender, July 2007-September 2008
Treating nail fungus— prescription vs. non-prescription products
Figure 48: Usage of prescription products, by gender, July 2007-September 2008
Attitudes towards OTC medicated skincare products
Figure 49: Attitudes towards OTC products, by gender, July 2007-September 2008
Figure 50: Attitudes towards OTC products, by age, July 2007-September 2008
SEVERITY OF AILMENTS AND TREATMENT METHODOLOGY
Ailment severity
Figure 51: Level of severity by ailment, January 2009
Method of treatment for cuts and scrapes
Figure 52: Preferred method of treatment for minor cuts/scrapes by gender, January 2009
Figure 53: Preferred method of treatment for minor cuts/scrapes by age, January 2009
Preferred method of treatment by ailment
Figure 54: Preferred method of treatment for rashes/cracked skin, January 2009
Figure 55: Preferred method of treatment for cold sores/chapped lips, January 2009
Preferences and purchasing behavior
Figure 56: Attitudes towards product attributes and purchasing behavior, by gender, January 2009
THE TEEN CONSUMER—PRODUCT USAGE
TEENS AND FACIAL SKINCARE
Figure 57: Types of facial cleansing/medicated products used—teens, by age and gender, May 2007-
June 2008
Facial cleansing and medicated products
Figure 58: Forms of facial cleansing/medicated products used—teens, by gender, May 2006-June 2007
Figure 59: Forms of facial cleansing/medicated products used—teens, by gender, May 2006-June 2007
Figure 60: Brands of facial cleansing/medicated products used—teens, by gender, May 2007-June 2008
RACE AND HISPANIC ORIGIN
Usage of medicated skincare products
Figure 61: Medicated skincare products used, by race/Hispanic origin, July 2007-September 2008
Usage of different types of products
Figure 62: Medicated skincare products used, by race/Hispanic origin, July 2007-September 2008
Usage of first aid/antibiotic remedies
Figure 63: First Aid used, by race/Hispanic origin, July 2007-September 2008
Attitudes towards OTC medicated skincare products
Figure 64: Attitudes towards OTC products, by race/Hispanic origin, July 2007-September 2008
APPENDIX: OTHER USEFUL CONSUMER TABLES
Figure 65: Brand of first aid product used, by age, July 2007-September 2008
Figure 66: Usage of prescription products, by age, July 2007-September 2008
APPENDIX: TRADE ASSOCIATIONS
Order Form
       * Please reference product number R560-3902 when ordering or inquiring.
PUBLICATION:   Medicated Skincare Products - US
QTY. FORMAT PRICE TOTAL
  Online Download$3,995.00   
  Hard Copy Mail Delivery (Subject to Shipping Charges)$3,995.00   
  Global Site License$6,000.00   
  SUBTOTAL   
SHIPPING CHARGES
 (U.S. $25, Canada $35, Int'l $65) 		 
TOTAL  

CONTACT INFORMATION
PAYMENT INFORMATION
Name ____________________________________________ MasterCard VISA AmEx Discover

__________________________________
Account number                 Exp. date

__________________________________
Signature

__________________________________
Email

Please invoice
      (shipment on receipt of payment)
Payment enclosed
*CHECKS / WIRE TRANSFERS:
Checks must be paid in U.S. funds.
Please call for details.
Company ____________________________________________
Job Title ____________________________________________
Address ____________________________________________
City ____________________________________________
Company ____________________________________________
State ______________________________   Zip__________
Country ____________________________________________
Phone ____________________________________________
MindBranch, Inc.,     131 Ashland St., Suite 200 North Adams, MA  01247       tel: 800-774-4410     fax: +1-413-664-9791     www.mindbranch.com